Author:
Qiu Zhong-Ling,Wei Wei-Jun,Shen Chen-Tian,Song Hong-Jun,Zhang Xin-Yun,Sun Zhen-Kui,Luo Quan-Yong
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J Clin 65, 5–29, doi:
10.3322/caac.21254
(2015).
2. Brierley, J., Tsang, R., Panzarella, T. & Bana, N. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 63, 418–427, doi:
10.1111/cen.2005.63.issue-4
(2005).
3. Lin, J. D., Chao, T. C., Hsueh, C. & Kuo, S. F. High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol 16, 2609–2616, doi:
10.1245/s10434-009-0565-7
(2009).
4. Filesi, M., Signore, A., Ventroni, G., Melacrinis, F. F. & Ronga, G. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 39, 1542–1546 (1998).
5. Francis, Z. & Schlumberger, M. Serum thyroglobulin determination in thyroid cancer patients. Best Pract Res Clin Endocrinol Metab 22, 1039–1046, doi:
10.1016/j.beem.2008.09.015
(2008).